UNION therapeutics

Focus: UNION therapeutics is a private Danish biotech focused on small-molecule drug development across oncology, infectious diseases, neurology, cardiovascular, and respiratory indications. The company operates at an early stage with a diversified pipeline but limited public visibility on scale and funding.

Oncology Infectious Diseases Neurology Cardiovascular

Profile data last refreshed 3h ago · AI intelligence enriched 1w ago

Funding Stage

PRIVATE

Open Jobs

3+1 this month

Stable — net +1 jobs in 30d

3 added, 2 removed. Backfill posture.

Should You Work at UNION therapeutics?

AI assessment

UNION therapeutics offers early-stage innovation exposure but presents elevated risk due to limited hiring, cash-position opacity, and early-stage pipeline maturity; best fit for risk-tolerant scientists seeking deep technical ownership.

Why Work Here

Exposure to multiple therapeutic areas (5 domains) and diverse modalities including CAR-T, small molecules, and dermal formulations across 30 active programs provides broad technical skill-building.

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Slowing

Jobs decreasing

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

AI system

Rare Disorders

N/A

Clinical Trials (1)

NCT07650799AI-assisted Rare Disease Diagnosis

N/A

Help build intelligence for UNION therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage private company offers potential for meaningful impact on drug development and intellectual property contributions during formative years.

Currently hiring in IT (3 open roles), suggesting infrastructure investment and digital transformation opportunities for technical talent.

Watch Out For

Only 3 active job openings indicate minimal hiring velocity and limited near-term career mobility or growth opportunities within the organization.
Pipeline dominated by Phase 1 programs with only 2 Phase 3 trials; minimal near-term revenue catalysts or proof-of-concept milestones increase execution risk and valuation uncertainty.
No public financial data, funding details, or employee count available; opaque capital position and burn rate make long-term stability difficult to assess.

Generated by Claude from UNION therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Risk Factor Assessment for Acute Pulmonary Hypertension Crisis

Pulmonary Hypertension

N/A

Clinical Trials (1)

NCT07653958Risk Factor Assessment for Acute Pulmonary Hypertension Crisis

N/A

Adjusting dietary structure + exercise + behavioral intervention

Polycystic Ovary Syndrome

N/A

Clinical Trials (1)

NCT06545721Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome

N/A

Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With

Dilated Cardiomyopathy (DCM)

N/A

Clinical Trials (1)

NCT06741995Evaluating the Prognostic Impact of Anti-β1AR Antibodies and Anti-L-CaC Antibodies in Patients With Dilated Cardiomyopathy

N/A

Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

Triple Negative Breast Cancer

N/A

Clinical Trials (1)

NCT04145947Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients

N/A

EUS-guided celiac plexus neurolysis

Pancreatic Cancer

N/A

Clinical Trials (1)

NCT03940027EUS-guided Celiac Plexus Neurolysis for the Treatment of Abdominal Pain in Pancreatic Cancer

N/A

rapid GCs taper

Lupus Erythematosus, Systemic

N/A

Clinical Trials (1)

NCT05506033Optimization of Glucocorticoid Taper Strategies for SLE-ITP

N/A

EVM18001 Injection

System Lupus Erythematosus(SLE)

N/A

Clinical Trials (1)

NCT07470151Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

N/A

cohort study

RSV Infection

N/A

Clinical Trials (5)

NCT07540286A Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

Phase 2

NCT07667153Myeloid Bias in the Bone Marrow of Septic Patients and Its Correlation With Disease Severity and Prognosis: A Single-Center, Prospective Cohort Study

N/A

NCT07516275Prospective Cohort Study of Pheochromocytoma/Paraganglioma

N/A

+2 more

COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observat

COVID-19

N/A

Clinical Trials (1)

NCT04329559COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study

N/A

Contrast-enhanced ultrasound

Pancreatic Cancer

N/A

Clinical Trials (1)

NCT05729737Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer

N/A

Total laparoscopic pancreaticoduodenectomy

Pancreatic Ductal Adenocarcinoma

N/A

Clinical Trials (1)

NCT03138213Comparing Total Laparoscopic Versus Open Pancreaticoduodenectomy

N/A

Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated b

Cirrhosis

N/A

Clinical Trials (1)

NCT07368309Clinical Management Strategies for Patients With Cirrhosis and Esophagogastric Varices Complicated by Early-stage Upper Gastrointestinal Cancer

N/A

Debulking Atherectomy

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05670171Debulking Atherectomy Versus Stent Angioplasty for Limb Ischaemia of Diabetic Lower Limb Atherosclerosis-occlusive Disease.

N/A

Pancreatic elastase-1 in blood serum

Pancreatic Ductal Adenocarcinoma

N/A

Clinical Trials (1)

NCT06041009Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations

N/A

Oral and Fecal Sample Collection

Pancreatic Cancer

N/A

Clinical Trials (1)

NCT05689138Using Digestive Microbial Information to Enhance the Early Detection of Pancreatic Cancer

N/A

ds-MCE and EGD

Liver Cirrhosis

N/A

Clinical Trials (1)

NCT03748563Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis

N/A

Minimally-invasive pancreaticoduodenectomy

Pancreatic Carcinoma

N/A

Clinical Trials (1)

NCT03747588The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer

N/A

Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fin

Pancreatic Carcinoma

N/A

Clinical Trials (1)

NCT05171517Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy

N/A

Ginseng oligopeptide

Non-alcoholic Fatty Liver Disease

N/A

Clinical Trials (1)

NCT06167902The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial

N/A

high oleic sunflower oil

Phenylketonuria

N/A

Clinical Trials (1)

NCT00909012Quantitative Requirements of Docosahexaenoic Acid for Neural Function in Children With Phenylketonuria

N/A

Transcervical resection of septum

Infertility and Miscarriage

N/A

Clinical Trials (2)

NCT07611656A Multicenter, Prospective, Randomized Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resection on IVF-ET Outcomes in Infertile Patients With Non-recurrent Miscarriage

N/A

NCT07039097A Multicenter, Prospective, Randomized, Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resection on the Natural Pregnancy Outcomes in Patients With Non-recurrent Spontaneous Abortion

N/A

Dietary intervention / counseling

NAFLD

N/A

Clinical Trials (1)

NCT02458586Ernährungs-Interventions-Fettleber-Studie (Interventional Study on Nutritional Effects on NAFLD)

N/A

PaCO2

COVID-19 Acute Respiratory Distress Syndrome

N/A

Clinical Trials (1)

NCT05882474Correlation Between PaCO2 and Respiratory Effort in Patients With COVID-19 With Extracorporeal Membrane Oxygenation

N/A

Rituxan treatment

Duchenne Muscular Dystrophy (DMD)

N/A

Clinical Trials (1)

NCT07475754A Study to Evaluate the Safety and Tolerability of Rituxan in Duchenne Muscular Dystrophy

N/A

Molecular Profiling & drug testing in tumor organoids and PDXs

Advanced Colorectal Carcinoma

N/A

Clinical Trials (1)

NCT05883683Molecular Study and Precision Medicine for Colorectal Cancer

N/A

Vinegar 20ml

Pancreatic Cancer

N/A

Clinical Trials (1)

NCT05617872Vinegar-induced Collection of Duodenal Pancreatic Juice Via Endoscopic Ultrasound

N/A

PD-1/PD-L1 inhibitor

Non Small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT04835025Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer

N/A

Any Chinese government-recommended COVID-19 booster vaccine

COVID-19 Recurrent

N/A

Clinical Trials (1)

NCT06168032COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research

N/A

non

COVID-19

N/A

Clinical Trials (5)

NCT07561892Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).

Phase 4

NCT07788001A Non-inferiority Study of Indocyanine Green-guided Sentinel Lymph Node Mapping Versus Conventional Lymph Node Dissection in Esophageal Cancer

Phase 3

NCT07737249Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease

Phase 2

+2 more

Postural interventions based on pulmonary imaging

COVID-19

N/A

Clinical Trials (1)

NCT05679440Postural Changes and Severe COVID-19

N/A

ClorNovir®

COVID-19

N/A

Durvalumab

Non Small Cell Lung Cancer Stage III

N/A

Clinical Trials (2)

NCT07679399A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.

Phase 2

NCT04672759A Real-world Study of Durvalumab for Lung Cancer in China

N/A

Lobectomy-First

Non Small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT06577792Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

N/A

Entecavir

Liver Cirrhosis

N/A